129 related articles for article (PubMed ID: 21532293)
1. QT dispersion in patients with rheumatic mitral stenosis and its relation with echocardiographic findings and serum NT-proBNP levels.
Kılıçkesmez KO; Bulut G; Başkurt M; Coşkun U; Yıldız A; Küçükoğlu S
Turk Kardiyol Dern Ars; 2011 Apr; 39(3):183-90. PubMed ID: 21532293
[TBL] [Abstract][Full Text] [Related]
2. N-terminal proBNP plasma levels correlate with severity of mitral stenosis.
Iltumur K; Karabulut A; Yokus B; Yavuzkir M; Taskesen T; Toprak N
J Heart Valve Dis; 2005 Nov; 14(6):735-41. PubMed ID: 16359052
[TBL] [Abstract][Full Text] [Related]
3. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease.
Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N
Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791
[TBL] [Abstract][Full Text] [Related]
4. The effect of percutaneous balloon mitral valvuloplasty on N-terminal- pro B- type natriuretic peptide plasma levels in mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Erbay AR; Temizhan A; Aksu T; Saydam GS; Korkmaz S
Int Heart J; 2007 Sep; 48(5):579-90. PubMed ID: 17998767
[TBL] [Abstract][Full Text] [Related]
5. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
[TBL] [Abstract][Full Text] [Related]
6. Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis.
Arat-Ozkan A; Kaya A; Yigit Z; Balci H; Okçün B; Yazicioglu N; Küçükoglu S
Echocardiography; 2005 Jul; 22(6):473-8. PubMed ID: 15966931
[TBL] [Abstract][Full Text] [Related]
7. Serum N-terminal brain natriuretic peptide indicates exercise induced augmentation of pulmonary artery pressure in patients with mitral stenosis.
Kilickesmez KO; Ozkan AA; Abaci O; Camlıca H; Kocas C; Kaya A; Baskurt M; Yiğit Z; Kucukoğlu S
Echocardiography; 2011 Jan; 28(1):8-14. PubMed ID: 20738368
[TBL] [Abstract][Full Text] [Related]
8. [The diagnostic value of N-terminal B-type natriuretic peptide in diastolic heart failure: comparison with echocardiographic findings].
Tuğcu A; Yildirimtürk O; Aytekin S
Turk Kardiyol Dern Ars; 2009 Mar; 37(2):112-21. PubMed ID: 19404033
[TBL] [Abstract][Full Text] [Related]
9. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
Arikan S; Tuzcu A; Gokalp D; Bahceci M; Danis R
Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation.
Petracca F; Affuso F; Di Conza P; Micillo F; Castellano G; Guardasole V; Scopacasa F; Saccà L; Fazio S
J Cardiovasc Med (Hagerstown); 2009 Dec; 10(12):928-32. PubMed ID: 19606057
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis.
Eryol NK; Dogan A; Ozdogru I; Inanc MT; Kaya MG; Kalay N
Int J Cardiovasc Imaging; 2007 Oct; 23(5):569-74. PubMed ID: 17186137
[TBL] [Abstract][Full Text] [Related]
12. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis.
Erbay AR; Turhan H; Yasar AS; Bicer A; Senen K; Sasmaz H; Sabah I; Yetkin E
Int J Cardiol; 2005 Jun; 102(1):33-7. PubMed ID: 15939096
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.
Kremastinos DT; Hamodraka E; Parissis J; Tsiapras D; Dima K; Maisel A
Am Heart J; 2010 Jan; 159(1):68-74. PubMed ID: 20102869
[TBL] [Abstract][Full Text] [Related]
14. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
Cemri M; Arslan U; Kocaman SA; Cengel A
J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
[TBL] [Abstract][Full Text] [Related]
15. N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.
Fernandes F; Ramires FJ; Buck PC; Almeida IJ; Rabelo R; Dantas SA; Salemi VM; Halpern A; Mady C
Braz J Med Biol Res; 2007 Feb; 40(2):153-8. PubMed ID: 17273651
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
[TBL] [Abstract][Full Text] [Related]
17. Determinants of the reduction in B-type natriuretic peptide after mitral valve replacement in patients with rheumatic mitral stenosis.
Leszek P; Klisiewicz A; Janas J; Różański J; Rywik T; Piotrowski W; Korewicki J
Clin Physiol Funct Imaging; 2010 Nov; 30(6):473-9. PubMed ID: 20807228
[TBL] [Abstract][Full Text] [Related]
18. Plasma amino-terminal pro-B-type natriuretic peptide quantification in hypertrophic cardiomyopathy.
Arteaga E; Araujo AQ; Buck P; Ianni BM; Rabello R; Mady C
Am Heart J; 2005 Dec; 150(6):1228-32. PubMed ID: 16338263
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
Iltumur K; Yavavli A; Apak I; Ariturk Z; Toprak N
Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
[TBL] [Abstract][Full Text] [Related]
20. N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes.
Mady C; Fernandes F; Ramires FJ; Nastari L; Buck PC; Arteaga E; Ianni BM; Salemi VM
Braz J Med Biol Res; 2008 Aug; 41(8):664-7. PubMed ID: 18797698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
